Abstract: This invention relates to a new silage aid, process for preparation of this silage aid and use of the silage aid. The silage aid comprises at least one antioxidant selected from the group 2,6-di-tert-butyl-4-methylphenol (BHT), 3-tert-butyl-4-hydroxyanisole (BHA), tert-butylhydroquinone (TBHQ), tocopherol and gallates; at least one short chain caboxylic acid; and optionally at least one salt of said acid. These andoxidants are food approve. The present silage aid is useful for preservation of organic by-products, and particularly for protection of fish oil during a fish silage process.

Abstract: A process for reducing plant availability of heavy metals in substrates such as soils wherein the substrates treated with cross-linked polymethacrylates. The poly (meth)acrylates can be worked into the soils.

Abstract: The present invention relates to a method for the preparation of a complex NPK fertilizer in the form of granules or prills, and to a method for its preparation and to the related use of the fertilizer thereby obtained. In particular the present invention relates to a fertilizer containing as fertilizing elements Nitrogen N, Phosphor P, Potassium K, meso elements like Calcium Ca, Magnesium Mg, Sulphur S, and micro elements like Iron Fe, Manganese Mn, Zinc Zn, Copper Cu, Boron B and Molybdenum Mo.

Abstract: An amorphous solid cast feed product is made by solidifying a substantially liquid agricultural byproduct. The byproduct may be selected from stillage, condensed fermented corn solubles, stillage, condensed distillers solubles, whey, condensed whey solubles, or any mixture thereof. The amorphous solid cast feed product may further include an exogenous source of a carbohydrate, a fat, a vitamin, a mineral, and/or nitrogen, as well as a sulfonated lignin material, a recycled animal waste product, and/or another miscellaneous fibrous material. The substantially liquid agricultural byproduct may first be condensed by heat, then solidified by being cooled in a mold. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 C.F.R. §1.72(b).

Abstract: The invention has the object of offering a novel means for making effective use of organic wastes, and offering a method for producing a feed by efficiently treating organic wastes. The invention has the additional object of enabling highly concentrated organic wastes to be treated efficiently in a short time. In a treatment method where molds are mixed with organic wastes to ferment and dry, the oil content of the mixture is adjusted to at least 3 wt %, preferably at least 5 wt %, more preferably at least 10 wt %.

Abstract: The invention concerns a method for the production of an organic fertilizer of humic-like nature, by oxidising and ammoniating treatment of lignite, characterised by the fact that lignite is suspended in a aqueous ammoniacal medium of pH>9 to 12 and in this context is partially dissolved and is oxidised at a temperature of 20-100° C. at normal pressure; and the organic fertilizer being obtained as a dispersion in aqueous medium, by thickening, or by drying, with a C/N ratio from 9 to 15. An organic fertilizer as well as its use is described. The process enables the production of an organic fertilizer from lignite distinguished by a humus-like structure and slow-releasing fertilization effect, and its use as such or as an addition to yield-increasing and soil-ameliorating substrates.

Abstract: Improved milk replacer and dry feed compositions for young mammals are provided that employ a high quality inedible egg product to minimize or eliminate the need for milk source ingredients or plasma-enhanced food compositions. These improved compositions include one or more high quality inedible egg products in an amount from about 1% to 100% of the total weight of the composition. The balance of these improved compositions may consist of any ingredient(s) in any combination when such composition is capable of meeting or exceeding the nutritional requirements of the species to be fed.

Abstract: An animal food includes an aromatic substance identical with that of meat, offals of animals or a combination thereof, and which is an extract from the meat, offals or the combination thereof. An extract of vegetables is also included in the animal food. Water is added for forming an animal beverage with the percentage of the extracts of meat, offals, vegetables or a combination thereof being no more than 8% of the total weight of the animal beverage.

Abstract: A diet which induces a state of ketosis in a canine or feline which comprises an edible composition relatively high in fats and relatively low in carbohydrates.

Abstract: A pet food product includes a mixture of chopped carrots; water; rolled oats; and an acidifying agent, glucono delta lactone. The mixture preferably includes 2.8 percent to 4.9 percent carrots; 67.00 percent to 89.0 percent water; 3.20 percent to 9.9 percent oats; 3.00 percent to 10.25 percent molasses; and 0.20 percent to 1.25 percent glucono delta lactone, all percentages being by weight. A method is provided of making the pet food product which is edible when frozen, the method including the steps of mixing food product ingredients to form a mixture; heating the mixture to a temperature for sufficient length of time to achieve sterilization of the mixture; packing the mixture while the mixture is maintained at a sterilizing temperature within a product package; substantially hermetically sealing the mixture within the product package; and storing the mixture at ambient temperature.

Abstract: The present invention relates to a hydroxy acid or a product containing thereof and a product made containing the same. The invention is characterized by the use of the hydroxy acid as a feed additive, either alone or in combination with other useful compounds or a product containing the same.

Abstract: The invention relates to fibrin sealants. More specifically, the invention relates to the use of a fibrin sealant wherein a composition comprising fibrin monomer or a composition comprising noncrosslinked fibrin is utilized as a component of the fibrin sealant.

Abstract: Glyco-amino acids or glycopeptides that have three-dimensionally stable configuration for the presentation of functional groups, fucose, or an analogue or derivative thereof, covalently linked to an amino acid or peptide with a free carboxylic acid group, that facilitate binding between those groups and receptors on selectins, represented by the general structural formula I.

Abstract: A transmucosal therapeutic composition comprising a physiologically active peptide or protein and a cytidine nucleotide derivative is described. The above composition results in a satisfactory transmucosal absorption of physiologically active peptides or proteins which are otherwise hardly absorbed from the mucosa. Since it allows self-administration to the mucosa, such as the nasal, vaginal or digestive tract mucosa, in lieu of injection which causes pain, the invention is of great utility as a pharmaceutical dosage form for physiologically active peptides or proteins which must be administered over a protracted time.

Abstract: The invention is directed to a method for the prophylaxis or treatment of an animal for deleterious physiological effects such as systemic hypotension caused by nitric oxide production induced by a biological response modifier. Examples of such biological response modifiers include but are not limited to a cytokine and an endotoxin. The invention is also directed to a method for the treatment of septic shock. Hemoproteins such as hemoglobin, myoglobin, hemalbumin and methemalbumin, for example, are useful when administered to a hypotensive patient.

Abstract: A thrombolytic peptide composed of 136 amino acids residues, which has little problems of antigenicity and is efficacious in only small doses as compared with staphylokinase (SAK). This peptide is obtained by cleaving amino acids or peptides which do not affect the activity of SAK by using a trypsin protease. In particular, SAK-11, which is obtained by cleaving a peptide composed of ten amino acid residues at the N-terminal of SAK, is superior to SAK in the fibrinolysis, plasminogen activation, and fibrin specificity.

Abstract: The present invention provides a therapeutic method of treating a human subject for psoriasis which comprises administering to the subject an effective psoriatic dermatosis-inhibiting amount of IL-2 and a pharmaceutically acceptable carrier.

Abstract: Therapeutic compositions and methods for the treatment of inflammation are disclosed. The compositions comprise at least one anti-inflammatory drug in combination with the lymphokine interleukin-4 (IL-4), which components interact synergistically in the treatmement of inflammation. Methods for the treatment of inflammation comprise administering to a subject in need of such treatment an effective amount of at least one anti-inflammatory drug and IL-4.

Abstract: Mammalian adipogenic factors, including purified proteins or glycoproteins, capable of inducing the adipose differentiation of adipogenic cells are disclosed, as are antibodies to such proteins, DNA encoding the proteins and host cells expressing the proteins. A method for determining the susceptibility of a subject to obesity by measuring the levels of one or more adipogenic factors in a biological fluid or tissue extract is also disclosed, as is a method for evaluating an anti-obesity drug which comprises contacting the drug with cells capable of producing one or more adipogenic factors and measuring the amount of the factors produced.

Abstract: Cholesterol reductase is administered to humans to convert cholesterol to coprostanol in the small intestine thus decreasing the bloodstream cholesterol level.